|
|||||
|
|
Immunogenicity of the BNT162b2 vaccine in frail or disabled nursing home residents: COVID-A study |
|
| Authors: | Sergio Salmerón Ríos MD PhD Marta Mas Romero RN Elisa Belén Cortés Zamora RN María Teresa Tabernero Sahuquillo BE Luis Romero Rizos MD PhD Pedro Manuel Sánchez-Jurado MD PhD Ginés Sánchez-Nievas MD José Joaquín Blas Señalada MD Inmaculada García Nogueras MD PhD Juan de Dios Estrella Cazalla MD Fernando Andrés-Pretel BS Antonio Murillo Romero MD Volker Martin Lauschke PhD Justin Stebbing MD PhD Pedro Abizanda MD PhD |
| Institution: | 1. Residencia de Mayores San Vicente de Paúl, Diputación de Albacete, Albacete, Spain;2. Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain;3. Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain
CIBERFES, Ministerio de Economía y Competitividad, Spain Facultad de Medicina, Universidad de Castilla-La Mancha, Albacete, Spain;4. Department of Rheumatology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain;5. Department of Microbiology, Complejo Hospitalario Universitario de Albacete, Albacete, Spain;6. Department of Geriatrics, Complejo Hospitalario Universitario de Albacete, Albacete, Spain CIBERFES, Ministerio de Economía y Competitividad, Spain Diputación de Albacete, Vasco Núñez de Balboa Facility, Albacete, Spain;7. Department of Statistics, Foundation of the National Paraplegics Hospital of Toledo, Toledo, Spain;8. Long-Term Care Facilities Coordination, Complejo Hospitalario Universitario de Albacete, Albacete, Spain;9. Department of Physiology and Pharmacology, Karolinska Institutet, Stockholm, Sweden;10. Department of Surgery and Cancer, Imperial College, Hammersmith Hospital, ICTEM building, London, United Kingdom |
| Abstract: | |
| Keywords: | BNT162b2 vaccine COVID-19 disability frailty immunogenicity older adults |